The trial closed early due to poor accrual and failed to reach statistical significance for the primary endpoint of three-year OS, but notable secondary measures favored the CRT arm.
← all excerpts
Perspectives on the Current Role of Radiation in the Management of Gastroesophageal Adenocarcinomas.
1
—
—